rdf:type |
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0032854,
umls-concept:C0205462,
umls-concept:C0231174,
umls-concept:C0332257,
umls-concept:C0449774,
umls-concept:C0476089,
umls-concept:C0600688,
umls-concept:C1274040,
umls-concept:C1522449,
umls-concept:C1522673,
umls-concept:C1561558,
umls-concept:C2348519
|
pubmed:issue |
2
|
pubmed:dateCreated |
2002-9-23
|
pubmed:abstractText |
To evaluate the long-term results of treatment using adjuvant whole abdominal irradiation (WAPI) with a pelvic/vaginal boost in patients with Stage I-III endometrial carcinoma at high risk of intra-abdominopelvic recurrence, including clear cell (CC) and serous-papillary (SP) histologic features.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0360-3016
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
527-35
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12243832-Actuarial Analysis,
pubmed-meshheading:12243832-Adenocarcinoma, Clear Cell,
pubmed-meshheading:12243832-Adult,
pubmed-meshheading:12243832-Aged,
pubmed-meshheading:12243832-Aged, 80 and over,
pubmed-meshheading:12243832-Analysis of Variance,
pubmed-meshheading:12243832-Cystadenocarcinoma, Papillary,
pubmed-meshheading:12243832-Endometrial Neoplasms,
pubmed-meshheading:12243832-Female,
pubmed-meshheading:12243832-Follow-Up Studies,
pubmed-meshheading:12243832-Humans,
pubmed-meshheading:12243832-Middle Aged,
pubmed-meshheading:12243832-Neoplasm Staging,
pubmed-meshheading:12243832-Prospective Studies,
pubmed-meshheading:12243832-Radiotherapy,
pubmed-meshheading:12243832-Radiotherapy, Adjuvant,
pubmed-meshheading:12243832-Survival Rate,
pubmed-meshheading:12243832-Treatment Failure
|
pubmed:year |
2002
|
pubmed:articleTitle |
Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.
|
pubmed:affiliation |
Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|